What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?
| Image |  |
|---|---|
| Description | scientific article published on 22 May 2019 |
| Author/s | |
| Publication date | May 22, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |